1 tracked superinvestor hold Adma Biologics Inc (ADMA), worth $14M combined, led by Stanley Druckenmiller. Smart money is accumulating ADMA as of the latest 13F filings.
Current price
$9.27
-50.8%
1Y
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG…
Market cap
$2.4B
P/E
17.53
Div yield
0.0%
Revenue YoY
19.6%
Analyst target
$21
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$14M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating ADMA: 1 funds added or opened versus 0 trimming.
Adma Biologics Inc (ADMA) is held by 1 tracked funds worth $14M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 0 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Added | 0.4% | $14M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own ADMA?
1 tracked funds hold Adma Biologics Inc (ADMA), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.4% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling ADMA?
In the most recent 13F quarter, 1 tracked fund added or opened ADMA and 0 trimmed it.
How much ADMA do tracked funds hold?
Combined disclosed long exposure to ADMA across tracked superinvestors is $14M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.